Advertisement
Screener

IRIDEX CORP (IRIX) Gain (Loss) Related to Litigation Settlement

1.2 / 5 stars · 28/120 Roast Me

IRIDEX CORP Gain (Loss) Related to Litigation Settlement

IRIDEX CORP (IRIX) reported Gain (Loss) Related to Litigation Settlement of $0 for the 3-month period ending 2013-09-28, per its 10-Q filed 2013-11-04.

Discontinued › Income Statement › Other Income

us-gaap:GainLossRelatedToLitigationSettlement · last filed 2014-03-27

  • IRIDEX CORP gain (loss) related to litigation settlement for the quarter ending 2013-09-28 was $0.00.
  • IRIDEX CORP gain (loss) related to litigation settlement for the quarter ending 2013-06-29 was $0.00, a 100.00% decline year-over-year.
  • IRIDEX CORP gain (loss) related to litigation settlement for the quarter ending 2012-12-29 was $0.00.
  • IRIDEX CORP gain (loss) related to litigation settlement for the quarter ending 2012-09-29 was $0.00.
  • IRIDEX CORP gain (loss) related to litigation settlement for fiscal 2012 was $800.00K, a 0.00% change from fiscal 2011.
  • IRIDEX CORP gain (loss) related to litigation settlement for fiscal 2011 was $800.00K, a 0.00% change from fiscal 2011.
  • IRIDEX CORP gain (loss) related to litigation settlement for fiscal 2011 was $800.00K, a 0.00% change from fiscal 2010.
  • IRIDEX CORP gain (loss) related to litigation settlement for fiscal 2010 was $800.00K.
Period endGain (Loss) Related to Litigation Settlement 3 monthGain (Loss) Related to Litigation Settlement 6 monthGain (Loss) Related to Litigation Settlement 9 monthGain (Loss) Related to Litigation Settlement 12 month
2013-09-28$0.00
10-Q · filed 2013-11-04
$0.00
derived: sum of 2 quarters · filed 2013-11-04
$0.00
10-Q · filed 2013-11-04
2013-06-29$0.00
10-Q · filed 2013-08-05
$0.00
10-Q · filed 2013-08-05
2012-12-29$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
$0.00
derived: sum of 2 quarters · filed 2014-03-27
$800.00K
derived: sum of 3 quarters · filed 2014-03-27
$800.00K
10-K · filed 2014-03-27
2012-09-29$0.00
10-Q · filed 2013-11-04
$800.00K
derived: sum of 2 quarters · filed 2013-11-04
$800.00K
10-Q · filed 2013-11-04
2012-06-30$800.00K
10-Q · filed 2013-08-05
$800.00K
10-Q · filed 2013-08-05
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
$0.00
derived: sum of 2 quarters · filed 2014-03-27
$800.00K
derived: sum of 3 quarters · filed 2014-03-27
$800.00K
10-K · filed 2014-03-27
2011-10-01$0.00
10-Q · filed 2012-11-05
$800.00K
derived: sum of 2 quarters · filed 2012-11-05
$800.00K
10-Q · filed 2011-11-04
2011-07-02$800.00K
10-Q · filed 2012-08-07
$800.00K
10-Q · filed 2012-08-07
2011-01-01$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$0.00
derived: sum of 2 quarters · filed 2013-03-28
$800.00K
derived: sum of 3 quarters · filed 2013-03-28
$800.00K
10-K · filed 2013-03-28
2010-10-02$0.00
10-Q · filed 2011-11-04
$800.00K
derived: sum of 2 quarters · filed 2011-11-04
$800.00K
10-Q · filed 2011-11-04
2010-07-03$800.00K
10-Q · filed 2011-08-04
$800.00K
10-Q · filed 2011-08-04
2010-01-02$800.00K
10-K · filed 2012-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B